Showing results (471-480 of 981) with videos related to
Sort By:
Pageof 99
Cardiovascular Therapeutics|November 26, 2010
Differences in angiotensin convertase enzyme (ACE) activity and expression may contribute to shorter event free period after coronary artery bypass graft surgeryAndrea Daragó, Miklós Fagyas, Ivetta M Siket, et al.Cardiovascular Therapeutics|November 13, 2010
Biomarkers in atrial fibrillation, ventricular arrhythmias, and sudden cardiac deathStavros Mountantonakis, Rajat DeoCardiovascular Therapeutics|May 25, 2010
Sugar and stroke: cerebrovascular disease and blood glucose controlT J Quinn, J Dawson, M R WaltersCardiovascular Therapeutics|August 20, 2010
Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?Carlos Escobar, Vivencio Barrios, David JimenezCardiovascular Therapeutics|July 15, 2010
Future of anticoagulant therapyJob Harenberg, Martin WehlingCardiovascular Therapeutics|July 15, 2010
Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjectsNobuhiro Tahara, Sho-Ichi Yamagishi, Takanori Matsui, et al.Cardiovascular Therapeutics|July 15, 2010
Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsMatteo Cesari, Marco Pahor, Raffaele Antonelli IncalziCardiovascular Therapeutics|July 15, 2010
Alternatives to warfarin--the next generation of anticoagulantsPamala Kanagasabapathy, Pratima Chowdary, Alex GattCardiovascular Therapeutics|June 19, 2010
Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stentingJavad Kojuri, Yadollah Mahmoody, Bardia Zangbar Sabegh, et al.Cardiovascular Therapeutics|June 10, 2010
Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trialHenry Krum, Dirk J van Veldhuisen, Christian Funck-Brentano, et al.Pageof 99